Chronic Disease
Conditions
Brief summary
The investigators have designed a three dose level, cross-over vegetable feeding study using expertise from nutritional sciences and plant sciences to: 1. Implement a randomized vegetable feeding trial among overweight post- menopausal women 2. Produce, in a controlled environmental setting, vegetable crops which provide a selected variety and quantity of carotenoid and nutrient exposure 3. Assess changes and hopefully demonstrate a significant reduction in oxidant stress and inflammation in this population at risk for developing chronic disease
Detailed description
Women were randomly assigned a vegetable feeding dose order of consuming 2,5 & 10 servings/day of vegetables for 3 week periods, with feeding periods separated by 4 week washout periods, during which time a limited number of low biological value fruits and vegetables were eaten. This research will provide important and relevant information to fill several gaps in our current knowledge including a more thorough description of the oxidant stress and inflammatory status of overweight, postmenopausal women, assessment of the relevant daily dose of vegetables necessary to modulate biomarkers of oxidant stress and inflammation in overweight postmenopausal women and evaluation of the association between plasma nutrient and carotenoid levels in relation to changes in oxidant stress and inflammation in this population. Our long-term goal is to reduce chronic disease risk among at-risk post-menopausal females.
Interventions
OTHER2, 5 & 10 Vegetable doses
2,5 & 10 serving dose/day combination of fresh lettuce mix, baby carrots, red bell peppers & tomatoes consumed for 3 week intervals
Sponsors
United States Department of Agriculture (USDA)
University of Arizona
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
50 Years to 75 Years
Healthy volunteers
Yes
Inclusion criteria
1. Female; 2. Age 50 to 75 years of age; 3. Target to include 20% minority subjects. 4. Post-menopausal - defined as greater than 12 months without menses; or lab values indicative of post-menopausal status; 5. Waist to hip ratio of \> 0.85; 6. Body mass index (BMI) between 25.0 and 45 kg/m2 ; 7. Non-smoker; 8. Reported alcohol intake of \< 2 servings daily; 9. Reported stable body weight for previous 6 months; 10. In general good health with no history of cancer (other than non- melanoma skin cancer), diabetes, liver or renal disease; 11. No known allergies to or intolerances of leaf lettuce, tomato, carrots or peppers; 12. Willing and able to successfully complete run-in activities -
Exclusion criteria
1. Morbid obesity (BMI \> 45 kg/m2); 2. Medical diagnosis requiring a therapeutic diet (i.e, diabetes, hepatic disease, etc); 3. Smoking history within previous 6 months; 4. Consuming \> 5 servings of fruits/vegetables daily prior to study enrollment; 5. Regular use of anti-inflammatory medications; 6. Unwilling to discontinue dietary supplements with the exception of study provided multivitamin and/or calcium supplement; 7. Unwilling to adhere to study protocol including limiting fruit intake to 1 serving per day and excluding vegetable intake other than study provided and allowed vegetables. 8. Participating in greater than 10 hours of regularly scheduled physical activity weekly or participating in vigorous physical activity on a regular basis (i.e. daily running, contact sports, etc) as assessed using a validated physical activity assessment questionnaire.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serum high sensitivity c-reactive protein | Change between baseline and 3 weeks | Change in serum high sensitivity c-reactive protein |
| Urine Isoprostanes 8-epi-PGF2alpha | Change between baseline and 3 weeks | Change in Urine Isoprostanes 8-epi-PGF2alpha |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Body weight | Change between baseline and 3 weeks | Change in body weight |
| Waist/hip circumference | Change between baseline and 3 weeks | Change in waist/hip circumference |
| Plasma carotenoids | Change between baseline and 3 weeks | Change in plasma carotenoids. |
| Blood pressure | Change between baseline and 21 weeks | Change in blood pressure |
| Percent body fat | Change between baseline and 3 weeks | Change in % body fat |
| Physical activity - Arizona Activity Frequency Questionnaire | Change between baseline and 21 weeks | Change in physical activity. |
Countries
United States
Outcome results
None listed